Paratek Pharmaceuticals Financials

Paratek Pharmaceuticals Stock Summary

Paratek Pharmaceuticals competes with Corvus Pharmaceuticals, Immutep, Lyra Therapeutics, Equillium, and Hookipa Pharma. Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Paratek Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Boston, Massachusetts. Paratek Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 207 people.

Paratek Pharmaceuticals Key Financial Ratios

Paratek Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Paratek Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Paratek Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Paratek Pharmaceuticals competition to find correlations between indicators driving Paratek Pharmaceuticals's intrinsic value. More Info.Paratek Pharmaceuticals is regarded fourth in return on asset category among its peers. It is regarded second in profit margin category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Paratek Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Paratek Pharmaceuticals Market Pulse

Along with financial statement analysis, the daily predictive indicators of Paratek Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Paratek Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Paratek Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Paratek Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Paratek Pharmaceuticals's daily price indicators and compare them against related drivers.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

If you are still planning to invest in Paratek Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Paratek Pharmaceuticals' history and understand the potential risks before investing.